To Grow Further In China, Big Pharma Needs Innovative Commercial Models
This article was originally published in PharmAsia News
Executive Summary
China has now overtaken the U.S. in terms of the number of pharma sales reps employed by MNCs. How to manage such a large sales team in a high-turnover environment with fast-rising costs and declining productivity is a major challenge for Big Pharma, as outlined in a recent report from McKinsey.